The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam

References

• Abbott, R. B., Bader, R., Bajjali, L., ElSamen, T. A., Obeidat, T., Sboul, H., … Alabbadi, I. (2012). The price of medicines in Jordan: The cost of trade-based intellectual property. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 9(2), 75–85. doi: 10.1177/1741134312447499
   Google Scholar
• Akaleephan, C., Wibulpolprasert, S., Sakulbumrungsil, R., Luangruangrong, P., Jitraknathee, A., Aeksaengsri, A., … Tantivess, S. (2009). Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: Analysis of the effect of TRIPs-plus proposal. Health Policy, 91, 174–182. doi: 10.1016/j.healthpol.2008.12.009
   PubMed Web of Science ®Google Scholar
• Arup, C. J., & Plahe, J. (2016). Access to medicines in the mature TRIPS regime: A sceptical view. Retrieved from SSRN http://ssrn.com/abstract=2730395
   Google Scholar
• Baker, B. K. (2013). US’s proposed TPP transition period for middle-income parties is Fools Gold. Retrieved from http://infojustice.org/archives/31540
   Google Scholar
• Baker, B. K. (2016). Trans-Pacific Partnership provisions in intellectual property, transparency and investment chapters threaten access to medicines in the US and elsewhere. PLOS Medicine, 13(3), e1001970. doi: 10.1371/journal.pmed.1001970
   PubMed Web of Science ®Google Scholar
• Bhardwaj, K., & Oh, C. (2014). The Trans-Pacific Partnership agreement: Implications for access to medicines and public health. UNITAID, WHO.
   Google Scholar
• Chan, M. (2014, May 19). Health has an obligatory place in any post-2015 agenda. Address to the Sixty-seventh World Health Assembly, Geneva.
   Google Scholar
• Drahos, P. (2008). “Trust me”: Patent offices in developing countries. American Journal of Law & Medicine, 34, 151–174. doi: 10.1177/009885880803400205
   PubMed Web of Science ®Google Scholar
• Duong, A. T., Kato, M., Bales, S., Do, N. T., Minh Nguyen, T. T., Thanh Cao, T. T., & Nguyen, L. T. (2014). Costing analysis of national HIV treatment and care program in Vietnam. JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(1), e1–e7. doi: 10.1097/QAI.0b013e3182a17d15
   PubMed Web of Science ®Google Scholar
• Godoy, A. S., & Cerón, A. (2011). Changing drug markets under new intellectual property regimes: The view from Central America. American Journal of Public Health, 101(7), 1186–1191. doi: 10.2105/AJPH.2010.300071
   PubMed Web of Science ®Google Scholar
• Government of Vietnam. (2012). Annual report of the HIV prevention and control program 2013 and plan for 2014. Ministry of Health.
   Google Scholar
• Government of Vietnam. (2013). Prime Minister’s decision on approval of the project on sustainable financing for HIV/AIDS prevention and control activities in 2013-2020 period. Hanoi, Vietnam.
   Google Scholar
• Harris, T., Nicol, D., & Gruen, N. (2013). Pharmaceutical patents review report. Canberra. Retrieved from http://www.ipaustralia.gov.au/pdfs/2013-05-27_PPR_Final_Report.pdf
   Google Scholar
• Hemphill, C. S., & Sampat, B. N. (2012). Evergreening, patent challenges, and effective market life in pharmaceuticals. Journal of Health Economics, 31, 327–339. doi: 10.1016/j.jhealeco.2012.01.004
   PubMed Web of Science ®Google Scholar
• IFARMA and Fundacion Mision Salud. (2009a). Impact of the EU-Andean trade agreement on access to medicines in Colombia.
   Google Scholar
• IFARMA and Fundacion Mision Salud. (2009b). Impact of the EU-Andean trade agreement on access to medicines in Peru.
   Google Scholar
• Inside U.S. Trade. (2013, November 27). In TPP, U.S. floats 12-year data period for biologics, flexibilities for developing countries. Posted.
   Google Scholar
• Kessomboon, N., Limpananont, J., Kulsomboon, V., Maleewong, U., Eksaengsri, A., & Paothong, P. (2010). Impact on access to medicines from TRIPS-plus: A case study of Thai-US FTA. Southeast Asian Journal of Tropical Medicine and Public Health, 41(3), 667–677.
   PubMed Web of Science ®Google Scholar
• Kiliç, B., & Maybarduk, P. (2011, June). Comparative analysis of the United States’ TPFTA intellectual property proposal and Vietnamese Law. Public Citizen (updated December 2011). Retrieved from www.citizen.org/access
   Google Scholar
• Labonté, R., Schram, A., & Ruckert, A. (2016). The Trans-Pacific Partnership: Is it everything we feared for health? International Journal of Health Policy and Management, 5(8), 487–496. doi: 10.15171/ijhpm.2016.41
   PubMed Web of Science ®Google Scholar
• Lexchin, J., & Gagnon, M.-A. (2014). CETA and pharmaceuticals: Impact of the trade agreement between Europe and Canada on the costs of prescription drugs. Globalization and Health, 10, 30. doi:10.1186/1744-8603-10-30.
   PubMed Web of Science ®Google Scholar
• Lopert, R., & Gleeson, D. (2013). The high price of “free” trade: U.S. Trade agreements and access to medicines. Global Health and the Law, 41(1), 199–223.
   Google Scholar
• Médecins Sans Frontières. (2013a). Untangling the web of antiretroviral price reductions (16th ed.). Retrieved from http://www.msfaccess.org/sites/default/files/AIDS_Report_UTW16_ENG_2013.pdf
   Google Scholar
• Médecins Sans Frontières. (2013b). As Trans-Pacific trade talks accelerate, vital lifeline of affordable medicines under threat. Retrieved from http://msfaccess.org/sites/default/files/MSF_UTW_17th_Edition_4_b.pdf
   Google Scholar
• Ministry of Health. (2009). National guidelines for HIV/AIDS diagnosis and treatment. Retrieved from https://aidsfree.usaid.gov/sites/default/files/hts_policy_vietnam.pdf.
   Google Scholar
• Moir, H. V. J. (2013). Fabricating invention: The patent malfunction of Australian patent law. Agenda, 20(2), 21–38.
   Google Scholar
• Moir, H. V. J., & Palombi, L. (2013). Patents and trademarks: empirical evidence on ‘evergreening’ from Australia. Paper presented at 4th Asia-Pacific Innovation conference, National Taiwan University, Taipei. Retrieved from http://ssrn.com/abstract=2365786
   Google Scholar
• Moir, H. V. J., Tenni, B., Gleeson, D. H., & Lopert, R. (2014). Assessing the impact of alternative patent systems on the cost of health care: the TPPA and HIV treatment in Vietnam. Paper presented at 5th Asia-Pacific Innovation conference, University of Technology, Sydney. Retrieved from http://ssrn.com/abstract=2536254
   Google Scholar
• National Committee for AIDS, Drugs, Prostitution Prevention and Control. (2014). Vietnam AIDS response progress report. Following up the 2011 political declaration on HIV AIDS. Reporting period January 2012–December 2013. Hanoi.
   Google Scholar
• Nguyen, A. T., Knight, R., Mant, A., Cao, Q. M., & Brooks, G. (2010). Medicine pricing policies: Lessons from Vietnam. Southern Med Review, 3(2), 12–19.
   Google Scholar
• Nguyen, A. T. (2011). Medicine prices and priccing policies in Vietnam (PhD thesis). Faculty of medicine, University of New South Wales.
   Google Scholar
• Nguyen, N. L., Nguyen, T. H., & Hua, T. (2015). Evolving trade policy and the Trans-Pacific Partnership Agreement: Does it threaten Vietnam’s access to medicine and its progress towards scaling up HIV prevention, treatment and care? Global Public Health, 10(1), S149–S160.
   PubMed Web of Science ®Google Scholar
• Oxfam International. (2007). All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines.
   Google Scholar
• Shaffer, E. R., & Brenner, J. E. (2009). A trade agreement’s impact on access to generic drugs. Health Affairs, 28(5), w957–w968. doi: 10.1377/hlthaff.28.5.w957
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2013). Viet Nam: South-South learning helps prepare for sustainable provision of AIDS treatment. Retrieved May 3, 2016, from http://www.unaids.org/en/resources/presscentre/featurestories/2013/may/20130516vietnam
   Google Scholar
• United States Secretary of State. (2015). Vietnam country operational plan 2015 – Strategic direction summary.
   Google Scholar
• US Trade Representative. (2013). Stakeholder input sharpens, focuses U.S. work on pharmaceutical intellectual property rights in the Trans-Pacific Partnership (Media Release). Retrieved August 4, 2014, from http://www.ustr.gov/about-us/press-office/blog/2013/November/stakeholder-input-sharpens-focuses-us-work-on-pharmaceutical-IP-in-TPP
   Google Scholar